FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to 2-pyridone compounds, represented by general formula [1], 
, where A represents benzene ring or pyridine ring, X represents structure, represented by general formula 
[3], V represents single bond or lower alkylene, W represents single bond, ether bond or lower alkylene, which can include ether bond, or their tautomers or stereoisomers.
EFFECT: obtaining pharmaceutically acceptable salts, which possess excellent activating activity with respect to GK and can be applied as medications.
27 cl, 23 tbl, 371 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CONDENSED 4-OXOPYRIMIDINE DERIVATIVE | 2005 |
|
RU2358969C2 |
| PYRAZOLE DERIVATIVES | 2004 |
|
RU2332412C2 |
| PHARMACEUTICAL COMPOSITIONS AND THEIR APPLICATIONS | 2002 |
|
RU2358733C2 |
| DERIVATIVES OF DIPHENYL, DERIVATIVE OF PHENYLPIPERAZINE, METHOD OF PATIENTS TREATMENT | 1995 |
|
RU2125051C1 |
| DICARBOXYLIC ACID COMPOUND | 2014 |
|
RU2662817C2 |
| PIRAZOLOQINOLINE DERIVATIVE | 2012 |
|
RU2605096C2 |
| CONDENSED HETEROCYCLIC DERIVATIVE, THERAPEUTIC COMPOSITION WHICH CONTAINS IT AND ITS APPLICATION IN MEDICINE | 2006 |
|
RU2418803C2 |
| 1,2,4-TRIAZOLONE DERIVATIVE | 2011 |
|
RU2566754C2 |
| NOVEL PIPERIDINE DERIVATIVES | 2006 |
|
RU2417985C2 |
| NOVEL COUMARIN DERIVATIVES WITH ANTI-TUMOUR ACTIVITY | 2007 |
|
RU2428420C2 |
